We design and deliver custom CRISPRi constructs for reversible, titratable gene repression in Corynebacterium glutamicum.
Accelerate metabolic engineering and functional genomics with tailored CRISPR interference. We provide end-to-end delivery – from sgRNA design to validated repressor strains.
We combine computational sgRNA design with robust dCas9 delivery to achieve efficient, specific transcriptional silencing in your target strain.
Bioinformatic design of single guide RNAs against target gene promoters or coding regions, optimized for C. glutamicum dCas9 activity and minimal off-target binding.
Cloning of validated sgRNAs into a CRISPRi plasmid carrying a catalytically dead Cas9 (dCas9) under a constitutive or inducible promoter, with selection markers suited for C. glutamicum.
Electroporation-mediated transformation into C. glutamicum, followed by antibiotic selection and colony PCR verification of plasmid maintenance.
Measurement of target gene repression by qRT-PCR and, where applicable, by growth phenotype or metabolite titer to confirm functional silencing.
Design and assembly of multiple sgRNAs in a single vector for simultaneous repression of several genes, enabling pathway-wide engineering.
Each project concludes with a documented set of engineered materials and a project report including methods, QC.
Each CRISPRi project is scoped individually based on your target genes, desired repression level, and downstream application. Key customization parameters include:
| Parameter | Typical project scope |
|---|---|
| Target Gene(s) | Single or up to multiple genes; promoter or coding strand target site selected during design |
| sgRNA Design Strategy | Bioinformatic design with off-target checking; number of sgRNAs per gene as scoped |
| dCas9 Expression System | Constitutive or inducible promoter (e.g., Ptac, Ptrc); dCas9-mediated steric repression is the standard bacterial mechanism |
| Vector Selection Marker | Kanamycin, chloramphenicol, or spectinomycin resistance; chosen per host strain |
| Validation Method | QRT-PCR for gene expression; optional phenotypic or metabolite assay depending on project goals |
| Multiplexing | Multiple sgRNAs in a single vector; array or polycistronic design evaluated during consultation |
Our streamlined CRISPRi service proceeds through five defined stages, from design to validated strain delivery.
We design sgRNAs targeting your gene(s) of interest using C. glutamicum-specific algorithms, synthesize oligonucleotides, and clone them into the CRISPRi vector.
The sgRNA expression cassette and dCas9 are assembled into a shuttle vector. Sequence verification confirms correct cloning before transformation.
Electrocompetent C. glutamicum cells are transformed with the validated CRISPRi plasmid. Transformed colonies are selected.
Individual colonies are screened by colony PCR and plasmid extraction to confirm the presence of the full CRISPRi construct. Positive clones are expanded.
Target gene expression is quantified by qRT-PCR relative to a control. If applicable, growth or production phenotypes are assessed. A final report is compiled.
Our service supports a range of metabolic engineering and research goals in this industrial workhorse.
Reversibly repress competing pathways or enzymes that divert flux away from the target product to redirect carbon flow toward desired products such as amino acids, organic acids.
Rapidly knock down gene expression to assess function. CRISPRi allows conditional knockdowns to study essential or conditionally essential genes without permanent knockout.
Combine multiple sgRNAs in one vector to simultaneously repress several genes, accelerating strain engineering for higher titers or yields.
Common questions about our CRISPRi service for Corynebacterium glutamicum.
Project timelines depend on the number of target genes, validation depth, and complexity. Typical projects range from 6 to 10 weeks, including design, construction, transformation, and validation. Your project manager will provide a detailed schedule during the scoping phase.
Yes, we routinely design and assemble vectors carrying multiple sgRNAs for multiplex repression. The number of sgRNAs and their arrangement (array or polycistronic) are evaluated during the consultation to support efficient repression of all targets.
We perform in silico off-target analysis for each sgRNA against the C. glutamicum genome. Functional off-target repression can be assessed by expression analysis of plausible off-target genes when included in scope; sequencing alone cannot confirm transcriptional specificity.
Each project includes a control strain transformed with the empty CRISPRi vector (dCas9 without sgRNA) and, when relevant, a non-targeting sgRNA control. These controls help assess background effects; independent guides or complementation can strengthen attribution of a phenotype to the intended target.
Get a customized quote for your Corynebacterium glutamicum CRISPRi Gene Repression project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.